Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2020-07-30 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Investor Presentation
Regulatory Filings
2020-07-30 English
Stock split
Interim / Quarterly Report Classification · 95% confidence The document is a communication from the company Laurus Labs Limited dated July 30, 2020, addressed to stock exchanges (BSE and NSE). It announces the outcome of a Board Meeting held on the same date. The key points include approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2020, pursuant to SEBI regulations. The document includes detailed financial data such as revenue, expenses, profit before tax, tax expense, net profit, and earnings per share for the quarter ended June 30, 2020, as well as comparative figures for previous quarters and the year ended March 31, 2020. The presence of detailed financial statements and analysis for a quarter indicates this is an Interim / Quarterly Report. Additionally, the document mentions the record date for a share subdivision (split), but the primary content is the financial results. The document length (15,000 characters) and detailed financial data confirm it is not merely an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2021
2020-07-30 English
Financial Result Updates
Regulatory Filings
2020-07-30 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 70% confidence The document contains details about a conference call including timing, dial-in numbers for various countries, and contact information for company representatives. There is no financial data, report content, or regulatory filing text. The presence of conference dial-in details strongly indicates this is a transcript or announcement related to a company conference call, likely an earnings call or investor call. Given the nature of the content, the document fits best under the category of Call Transcript (CT). The document length is short but contains the key elements of a call transcript announcement or invitation rather than a full transcript, but since it is not merely an announcement of a report publication, it is classified as CT with moderate confidence.
2020-07-27 English
Board Meeting — Financial Results
Regulatory Filings Classification · 90% confidence The document text is extremely short (63 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, report title, regulatory references, or any other information to classify it as a specific report type. Given the lack of content, the document cannot be classified as a report or announcement. According to the rules, such minimal or non-informative content defaults to Regulatory Filings (RNS) as a fallback category.
2020-07-21 English
Updates
Regulatory Filings Classification · 100% confidence The document text is extremely short (64 characters) and contains no substantive content, only a placeholder for an omitted picture. There is no financial data, no report content, no announcements, or any regulatory information. Given the lack of content, this cannot be classified as any substantive report or announcement. According to the rules, such minimal content with no report or announcement details defaults to Regulatory Filings (RNS) as a fallback category.
2020-07-20 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.